MSAM
WST icon

Moloney Securities Asset Management’s West Pharmaceutical WST Stock Holding History

Moloney Securities Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,449
Closed -$694K – 441
2020
Q4 		$694K Buy
2,449
+426
+21% +$120K 0.15% 161
2020
Q3 		$556K Buy
2,023
+87
+4% +$23K 0.15% 154
2020
Q2 		$440K Buy
+1,936
New +$380K 0.13% 169

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Moloney Securities Asset Management's WST Position: Q1 2021 in Review

Moloney Securities Asset Management sold out of West Pharmaceutical (WST) in Q1 2021, closing a stake of 2,449 shares — an estimated $694K sold.

Moloney Securities Asset Management first reported a position in WST in Q2 2020 and held it in 3 quarters. The position peaked at $694K in Q4 2020. 590 funds tracked by Wall St. Rank hold WST as of Q1 2021.

  • Moloney Securities Asset Management reported no remaining West Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Moloney Securities Asset Management sold 2,449 West Pharmaceutical shares in Q1 2021, an estimated $694K.
  • Moloney Securities Asset Management first reported a position in West Pharmaceutical in Q2 2020 and held it in 3 quarters.
  • Moloney Securities Asset Management's West Pharmaceutical position peaked at $694K in Q4 2020.
  • 590 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on Moloney Securities Asset Management's 13F filing for Q1 2021, filed 28 Apr 2021.